12:00 AM
 | 
Jan 20, 2014
 |  BC Week In Review  |  Company News  |  Other News

Axxam, Hit Discovery Constance, Lead Discovery Center, Centre for Drug Design and Discovery (CD3) supply/service, high throughput screening news

CRO Axxam, biotech Lead Discovery and the technology transfer platform and investment fund CD3 debuted their JV, Hit Discovery Constance GmbH, to provide drug discovery research services, including assay...

Read the full 121 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >